Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

SODIUM SUCCINATE

SODIUM SUCCINATE

Standard Dose
30%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview SODIUM SUCCINATE is listed in Drugs@FDA under application 080516 (ANDA).

Marketing status: Discontinued Active ingredient SODIUM SUCCINATE Form and strength INJECTABLE;INJECTION - 30% Sponsor ELKINS SINN Submission history Latest submission status date: 1983-03-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM SUCCINATE is listed in Drugs@FDA under application 080516 (ANDA). Marketing status: Discontinued Active ingredient SODIUM SUCCINATE Form and strength INJECTABLE;INJECTION - 30% Sponsor ELKINS SINN Submission history Latest submission status date: 1983-03-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
SODIUM SUCCINATE (SODIUM SUCCINATE) | Drug Monograph | MedicHelpline